Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
7.25M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
4.21M
-
Shares change
-
-269K
-
Total reported value, excl. options
-
$16.4M
-
Value change
-
-$1.45M
-
Number of buys
-
12
-
Number of sells
-
-11
-
Price
-
$3.90
Significant Holders of Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) as of Q3 2025
42 filings reported holding KZR - Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share as of Q3 2025.
Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.21M shares
of 7.25M outstanding shares and own 57.98% of the company stock.
Largest 10 shareholders include BML Capital Management, LLC (721K shares), TANG CAPITAL MANAGEMENT LLC (720K shares), SUVRETTA CAPITAL MANAGEMENT, LLC (717K shares), Stonepine Capital Management, LLC (383K shares), VANGUARD GROUP INC (268K shares), ORBIMED ADVISORS LLC (193K shares), ACADIAN ASSET MANAGEMENT LLC (134K shares), Peapod Lane Capital LLC (126K shares), ADAR1 Capital Management, LLC (125K shares), and RENAISSANCE TECHNOLOGIES LLC (116K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.